Skip to main content
Companion Animal Healthcare Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast 2024-2028

Companion Animal Healthcare Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast 2024-2028

Published: Jul 2024 137 Pages SKU: IRTNTR74077

Market Overview at a Glance

$10.84 B
Market Opportunity
10.03%
CAGR
8.88
YoY growth 2023-2024(%)

Companion Animal Healthcare Market Size 2024-2028 

The companion animal healthcare market size is forecast to increase by USD 10.84 billion at a CAGR of 10.03% between 2023 and 2028.

  • The market is experiencing significant growth due to several key factors. The rising trend of pet ownership in North America continues to drive market expansion. Moreover, increasing awareness about the importance of pet insurance and the need for comprehensive healthcare coverage is another major growth driver. Additionally, stringent regulatory approval processes for veterinary drugs ensure the production of safe and effective treatments, further boosting market growth. These trends are expected to continue shaping the market In the coming years.

What will be the Size of the Companion Animal Healthcare Market During the Forecast Period?

Companion Animal Healthcare Market Size

 Request Free Sample

  • The market encompasses a range of products and services aimed at promoting the health and well-being of pets. Pharmaceutical businesses play a significant role in this market, providing animal vaccines for various diseases, including Nipah infection and zoonotic illnesses, as well as treatments for food-borne illnesses. The market is experiencing dynamic growth due to increasing pet ownership, rising awareness of animal health, and advancements in veterinary healthcare, such as diagnostics, vaccines, and preventive care. The COVID-19 pandemic has also accelerated the adoption of telemedicine, health apps, and other digital solutions for animal care. Cruelty to animals is a growing concern, leading to increased demand for ethical animal health products.
  • Feed additives and preventive measures are also essential components of the market, as they help maintain animal health and reduce the risk of chronic conditions. Overall, the market is a thriving industry that prioritizes the health and well-being of pets while addressing the evolving needs of pet owners.

How is this Companion Animal Healthcare Industry segmented and which is the largest segment?

The companion animal healthcare industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Product
    • Pharmaceuticals
    • Diagnostics
  • Geography
    • North America
      • Canada
      • US
    • Europe
      • Germany
      • UK
    • Asia
      • China
    • Rest of World (ROW)

    By Product Insights

    • The pharmaceuticals segment is estimated to witness significant growth during the forecast period.

    The market is experiencing significant growth due to several factors. Pharmaceuticals represent the largest segment, driven by increasing pet ownership, the rise in zoonotic diseases, and the growing demand for pet insurance. Zoonotic diseases, such as rabies, blastomycosis, and salmonellosis, pose a threat to both animals and humans. Animals can act as early warning systems for potential human infections, making their health a critical concern. Animal health products, including vaccines and diagnostics, are essential for preventing and treating diseases. The COVID-19 pandemic has accelerated the adoption of telemedicine and health apps for preventive care and treatment of diseases. Regulatory requirements, veterinary healthcare advancements, and sustainable practices are shaping the market landscape.

    Geographical trends, consumer disposable incomes, and regulatory frameworks are key factors influencing market growth. The future outlook is positive, with opportunities in urbanization, emerging economies, and advanced medical technologies. Animal welfare and personalized medicine are also gaining importance. The market is segmented by animal type, product, and end user, with Europe having a significant presence. Challenges include regulatory hurdles, income levels, and pet care costs. Despite these challenges, the market is expected to grow, driven by advanced healthcare solutions and user-friendly testing kits for chronic condition monitoring.

    Companion Animal Healthcare Market Size

    Get a glance at the  Companion Animal Healthcare Industry report of share of various segments Request Free Sample

    The Pharmaceuticals segment was valued at USD 10.21 billion in 2018 and showed a gradual increase during the forecast period.

    Regional Analysis

    • North America is estimated to contribute 45% to the growth of the global market during the forecast period.

    Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

    Companion Animal Healthcare Market Share by Geography

    For more insights on the market share of various regions, Request Free Sample

    The North American the market is experiencing notable expansion, driven by the increasing pet ownership trend In the United States and Canada. Factors fueling market growth include a well-established animal health industry base, high adoption rates of companion animals, rising incidences of zoonotic diseases and food-borne illnesses, a substantial number of veterinary hospitals and clinics, a growing pool of veterinarians, and escalating animal health expenditures. Furthermore, pet humanization is significantly increasing the demand for companion animal healthcare during the forecast period. Key areas of focus within this market include animal vaccines, diagnostics, food additives, and preventive care for dogs, cats, and horses.

    Geographical trends indicate that urbanization and rising consumer disposable incomes are contributing to the market's expansion. Challenges and opportunities include regulatory hurdles, the emergence of telemedicine and health apps, and the development of advanced healthcare solutions, personalized medicine, and sustainable practices. The market is segmented by animal type (dogs, cats, and horses), product (animal health products, veterinary healthcare infrastructure, and veterinary services), and end user (professional breeders, equestrian sports, veterinary professionals, and veterinary practitioners). Regulatory framework, animal welfare, and advanced treatment options are crucial considerations for market players.

    Market Dynamics

    Our companion animal healthcare market researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

    What are the key market drivers leading to the rise In the adoption of Companion Animal Healthcare Industry?

    Rising pet ownership is the key driver of the market.

    • The market is experiencing significant growth due to the increasing trend of pet ownership and the humanization of pets In the US. According to the American Pet Products Association (APPA), approximately 85 million American households, or 67% of the total, own a pet. This rising pet population necessitates preventive care and treatment for various zoonotic illnesses, food-borne diseases, and chronic conditions. Pharmaceutical businesses are responding by developing animal health products, including animal vaccines and diagnostics, to meet this demand. Animal vaccinations are crucial in preventing diseases such as Nipah infection, which can be transmitted from animals to humans. Diagnostic techniques, such as clinical toxicology tests, are essential in identifying and treating zoonotic diseases and food-borne illnesses.
    • Regulatory requirements for animal healthcare products are stringent, ensuring the safety and efficacy of vaccines, diagnostics, feed additives, and other animal health solutions. The COVID-19 pandemic has accelerated the adoption of telemedicine, health apps, and in-home testing for companion animals. Preventive care, treatment of diseases, and chronic condition monitoring are increasingly being managed in home-care settings. Telehealth services and advanced healthcare solutions, such as personalized medicine and sustainable practices, are becoming more accessible to pet owners. Geographical trends, regulatory hurdles, and income levels influence the market's dynamics. Veterinary healthcare infrastructure, emerging economies, and animal health regulations are key factors shaping the market's future outlook.
    • The market is segmented by animal type (Dogs, Cats, Horses), product (Animal vaccines, Clinical biochemistry, Diagnostic laboratories, Home care settings), and end user (Professional breeders, Equestrian sports, Veterinary professionals, Veterinary hospitals, and Clinics). Animal welfare and advanced treatment options are driving the demand for Cat-specific healthcare products and Horse health solutions. Point-of-care testing and in-house testing are becoming increasingly popular due to their convenience and user-friendly nature. The market is expected to continue growing, driven by urbanization, consumer disposable incomes, and regulatory frameworks that prioritize animal health and welfare.

    What are the market trends shaping the Companion Animal Healthcare Industry?

    Rising awareness about pet insurance is the upcoming market trend.

    • The market encompasses various sectors, including animal vaccinations, pharmaceutical businesses, and animal health products. This market is driven by the need to prevent and treat zoonotic illnesses, such as Nipah infection, and food-borne diseases, which can impact both animals and humans. The COVID-19 pandemic has highlighted the importance of veterinary healthcare advancements, including clinical toxicology tests and diagnostic techniques, to ensure the health and well-being of companion animals. Regulatory requirements and hurdles are significant challenges In the market, with a focus on animal welfare and ethical considerations, such as cruelty to animals. The market is also influenced by geographical trends, urbanization, and consumer disposable incomes.
    • The European market presence is substantial, with a breakup by product, end user, and animal type. Preventive care, such as vaccines and feed additives, is a crucial aspect of the market, with a growing emphasis on personalized medicine and sustainable practices. Telemedicine, health apps, and in-home testing are emerging trends, offering advanced healthcare solutions for companion animals. Chronic condition monitoring and treatment of diseases are significant areas of investment, with a focus on advanced medical technologies and user-friendly testing kits. The market is segmented by animal, including dogs, cats, and horses, with equine health and horse health being significant areas of focus for professional breeders and equestrian sports.
    • Veterinary healthcare infrastructure and emerging economies are also essential factors influencing the market's growth. Animal health regulations and the availability of over-the-counter (OTC) and prescription animal health products are significant market drivers. The future outlook for the market is promising, with opportunities in diagnostics laboratories, research institutes and universities, and home care settings. Canine pet insurance and cat-specific healthcare products are gaining popularity, with a focus on veterinary practitioners and income level impacting pet care costs. The vaccine segment and clinical biochemistry segment are expected to dominate the market, with horses and diagnostic laboratories being significant contributors to the market's growth.

    What challenges does the Companion Animal Healthcare Industry face during its growth?

    Stringent regulatory approval processes for veterinary drugs is a key challenge affecting the industry growth.

    • The market encompasses a range of animal health products and services, including animal vaccinations, pharmaceutical businesses, and diagnostics. Animal health is of paramount importance, with a focus on preventing and treating zoonotic illnesses, such as Nipah infection, and food-borne diseases. Veterinary hospitals and clinical toxicology tests play a crucial role in ensuring animal health, while regulatory requirements and veterinary healthcare advancements continue to evolve. Animal vaccines are a significant segment of the market, with a growing demand for preventive care and advanced treatment options. The COVID-19 pandemic has highlighted the importance of animal health, leading to increased investment in veterinary healthcare infrastructure and research.
    • However, regulatory hurdles and geographical trends present challenges for pharmaceutical businesses. The market is also influenced by consumer disposable incomes, urbanization, and pet humanization. The breakdown of the market includes equine health, feed additives, telemedicine, health apps, and point-of-care testing. The European market presence is significant, with animal welfare and advanced medical technologies driving growth. Chronic conditions, such as diabetes and arthritis, are increasingly being monitored through in-home testing and personalized medicine. Sustainable practices are also gaining importance In the industry. The future outlook of the market is promising, with opportunities in emerging economies and the development of advanced healthcare solutions.
    • Veterinary practitioners and professional breeders are key end-users, with a growing demand for canine and feline-specific healthcare products. Horses, diagnostic laboratories, research institutes & universities, and home care settings are also significant contributors to the market. Regulatory frameworks, such as the US FDA, the Canadian Food Agency, the European Medicines Agency, and the Veterinary International Committee for Harmonization (VICH), play a vital role in approving veterinary medicines and harmonizing guidelines. Strict regulatory criteria for the authorization of novel veterinary pharmaceutical products are in place in countries like Australia, Japan, and China.

    Exclusive Customer Landscape

    The companion animal healthcare market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the companion animal healthcare market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

    Companion Animal Healthcare Market Share by Geography

     Customer Landscape

    Key Companies & Market Insights

    Companies are implementing various strategies, such as strategic alliances, companion animal healthcare market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

    Agrolabo Spa - The company specializes In the production and distribution of companion animal health products, encompassing brands such as Atopica, VETSPON, and Rabvac. These brands cater to various health concerns, ensuring optimal wellbeing for pets.

    The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

    • Agrolabo Spa
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Chanelle Pharma Group
    • Dechra Pharmaceuticals Plc
    • Eco Animal Health Group Plc
    • Elanco Animal Health Inc.
    • Endovac Animal Health
    • Heska Corp.
    • IDEXX LABORATORIES INC.
    • Indian Immunologicals Ltd.
    • Inovet
    • Kyoritsuseiyaku Corp.
    • HIPRA S A
    • Merck and Co. Inc.
    • Norbrook Laboratories Ltd.
    • Vetoquinol SA
    • Virbac Group
    • Zoetis Inc.

    Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

    Research Analyst Overview

    The market encompasses a broad range of products and services designed to promote and maintaIn the health and wellbeing of dogs, cats, and horses. This market is driven by several factors, including the increasing humanization of pets, rising consumer disposable incomes, and the availability of advanced healthcare solutions. One significant segment of the market is animal vaccines. These vaccines protect animals from various diseases, including zoonotic illnesses, which can be transmitted from animals to humans. The development of new vaccines and the improvement of existing ones continue to be a focus for pharmaceutical businesses, as they offer preventive care solutions that can save lives and reduce the economic burden of treating diseases.

    Another critical area of the market is diagnostics. Diagnostic techniques have advanced significantly in recent years, enabling veterinary professionals to identify diseases more accurately and at an earlier stage. Point-of-care testing and in-home testing kits have become increasingly popular, as they offer convenience and faster results for pet owners. Clinical toxicology tests are also essential in diagnosing and treating various conditions, particularly in emergency situations. Regulatory requirements play a significant role In the market. Regulations ensure that animal health products meet specific safety and efficacy standards, providing peace of mind for pet owners and veterinary professionals. However, these regulations can also create regulatory hurdles for businesses, particularly in emerging economies where regulatory frameworks may be less developed.

    The use of advanced medical technologies, such as telemedicine and health apps, is becoming more common In the market. These technologies offer convenience and accessibility, particularly in rural areas or for pets with chronic conditions. Telehealth services and user-friendly testing kits enable veterinary practitioners to provide care in a home-care setting, reducing the need for frequent visits to veterinary hospitals. The market for companion animal healthcare is diverse, with various animal types, product segments, and end-users. Dogs and cats are the most common companion animals, but horses also represent a significant market. The veterinary healthcare infrastructure varies by region, with Europe having a strong market presence due to its advanced veterinary healthcare system and high animal welfare standards.

    The challenges and opportunities In the market are numerous. Sustainable practices, such as the use of feed additives and the development of personalized medicine, offer potential solutions to some of these challenges. The future outlook for the market is positive, with continued advancements in veterinary healthcare infrastructure, regulatory frameworks, and technology driving growth. Urbanization and changing consumer preferences are also impacting the market. As more people move into urban areas, there is a growing demand for convenient and accessible healthcare solutions for their pets. Pet insurance is becoming increasingly popular, particularly for cats and dogs, as pet owners seek to manage the costs of veterinary care.

    In conclusion, the market is a dynamic and growing industry, driven by a range of factors, including the increasing humanization of pets, rising consumer disposable incomes, and the availability of advanced healthcare solutions. The market is diverse, with various animal types, product segments, and end-users, and is subject to regulatory requirements and challenges. Despite these challenges, the future outlook for the market is positive, with continued advancements in veterinary healthcare infrastructure, regulatory frameworks, and technology driving growth.

    Companion Animal Healthcare Market Scope

    Report Coverage

    Details

    Page number

    137

    Base year

    2023

    Historic period

    2018-2022

    Forecast period

    2024-2028

    Growth momentum & CAGR

    Accelerate at a CAGR of 10.03%

    Market growth 2024-2028

    USD 10840.4 million

    Market structure

    Fragmented

    YoY growth 2023-2024(%)

    8.88

    Key countries

    US, Germany, UK, Canada, and China

    Competitive landscape

    Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

    Request Free Sample

    What are the Key Data Covered in this Companion Animal Healthcare Market Research and Growth Report?

    • CAGR of the Companion Animal Healthcare industry during the forecast period
    • Detailed information on factors that will drive the Companion Animal Healthcare growth and forecasting between 2024 and 2028
    • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
    • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
    • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
    • Thorough analysis of the market’s competitive landscape and detailed information about companies
    • Comprehensive analysis of factors that will challenge the companion animal healthcare market growth of industry companies

    We can help! Our analysts can customize this companion animal healthcare market research report to meet your requirements.

    Get in touch

     

    1 Executive Summary

    • 1.1 Market overview
      • Executive Summary - Chart on Market Overview
      • Executive Summary - Data Table on Market Overview
      • Executive Summary - Chart on Global Market Characteristics
      • Executive Summary - Chart on Market by Geography
      • Executive Summary - Chart on Market Segmentation by Product
      • Executive Summary - Chart on Incremental Growth
      • Executive Summary - Data Table on Incremental Growth
      • Executive Summary - Chart on Company Market Positioning

    2 Market Landscape

    • 2.1 Market ecosystem
      • Parent Market
      • Data Table on - Parent Market
    • 2.2 Market characteristics
      • Market characteristics analysis
    • 2.3 Value chain analysis
      • Value Chain Analysis

    3 Market Sizing

    • 3.1 Market definition
      • Offerings of companies included in the market definition
    • 3.2 Market segment analysis
      • Market segments
    • 3.3 Market size 2023
      • 3.4 Market outlook: Forecast for 2023-2028
        • Chart on Global - Market size and forecast 2023-2028 ($ million)
        • Data Table on Global - Market size and forecast 2023-2028 ($ million)
        • Chart on Global Market: Year-over-year growth 2023-2028 (%)
        • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

      4 Historic Market Size

      • 4.1 Global Companion Animal Healthcare Market 2018 - 2022
        • Historic Market Size - Data Table on Global Companion Animal Healthcare Market 2018 - 2022 ($ million)
      • 4.2 Product segment analysis 2018 - 2022
        • Historic Market Size - Product Segment 2018 - 2022 ($ million)
      • 4.3 Geography segment analysis 2018 - 2022
        • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
      • 4.4 Country segment analysis 2018 - 2022
        • Historic Market Size - Country Segment 2018 - 2022 ($ million)

      5 Five Forces Analysis

      • 5.1 Five forces summary
        • Five forces analysis - Comparison between 2023 and 2028
      • 5.2 Bargaining power of buyers
        • Bargaining power of buyers - Impact of key factors 2023 and 2028
      • 5.3 Bargaining power of suppliers
        • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
      • 5.4 Threat of new entrants
        • Threat of new entrants - Impact of key factors in 2023 and 2028
      • 5.5 Threat of substitutes
        • Threat of substitutes - Impact of key factors in 2023 and 2028
      • 5.6 Threat of rivalry
        • Threat of rivalry - Impact of key factors in 2023 and 2028
      • 5.7 Market condition
        • Chart on Market condition - Five forces 2023 and 2028

      6 Market Segmentation by Product

      • 6.1 Market segments
        • Chart on Product - Market share 2023-2028 (%)
        • Data Table on Product - Market share 2023-2028 (%)
      • 6.2 Comparison by Product
        • Chart on Comparison by Product
        • Data Table on Comparison by Product
      • 6.3 Pharmaceuticals - Market size and forecast 2023-2028
        • Chart on Pharmaceuticals - Market size and forecast 2023-2028 ($ million)
        • Data Table on Pharmaceuticals - Market size and forecast 2023-2028 ($ million)
        • Chart on Pharmaceuticals - Year-over-year growth 2023-2028 (%)
        • Data Table on Pharmaceuticals - Year-over-year growth 2023-2028 (%)
      • 6.4 Diagnostics - Market size and forecast 2023-2028
        • Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
        • Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
        • Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
        • Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
      • 6.5 Market opportunity by Product
        • Market opportunity by Product ($ million)
        • Data Table on Market opportunity by Product ($ million)

      7 Customer Landscape

      • 7.1 Customer landscape overview
        • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

      8 Geographic Landscape

      • 8.1 Geographic segmentation
        • Chart on Market share by geography 2023-2028 (%)
        • Data Table on Market share by geography 2023-2028 (%)
      • 8.2 Geographic comparison
        • Chart on Geographic comparison
        • Data Table on Geographic comparison
      • 8.3 North America - Market size and forecast 2023-2028
        • Chart on North America - Market size and forecast 2023-2028 ($ million)
        • Data Table on North America - Market size and forecast 2023-2028 ($ million)
        • Chart on North America - Year-over-year growth 2023-2028 (%)
        • Data Table on North America - Year-over-year growth 2023-2028 (%)
      • 8.4 Europe - Market size and forecast 2023-2028
        • Chart on Europe - Market size and forecast 2023-2028 ($ million)
        • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
        • Chart on Europe - Year-over-year growth 2023-2028 (%)
        • Data Table on Europe - Year-over-year growth 2023-2028 (%)
      • 8.5 Asia - Market size and forecast 2023-2028
        • Chart on Asia - Market size and forecast 2023-2028 ($ million)
        • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
        • Chart on Asia - Year-over-year growth 2023-2028 (%)
        • Data Table on Asia - Year-over-year growth 2023-2028 (%)
      • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
        • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
        • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
        • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
        • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • 8.7 US - Market size and forecast 2023-2028
        • Chart on US - Market size and forecast 2023-2028 ($ million)
        • Data Table on US - Market size and forecast 2023-2028 ($ million)
        • Chart on US - Year-over-year growth 2023-2028 (%)
        • Data Table on US - Year-over-year growth 2023-2028 (%)
      • 8.8 Germany - Market size and forecast 2023-2028
        • Chart on Germany - Market size and forecast 2023-2028 ($ million)
        • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
        • Chart on Germany - Year-over-year growth 2023-2028 (%)
        • Data Table on Germany - Year-over-year growth 2023-2028 (%)
      • 8.9 UK - Market size and forecast 2023-2028
        • Chart on UK - Market size and forecast 2023-2028 ($ million)
        • Data Table on UK - Market size and forecast 2023-2028 ($ million)
        • Chart on UK - Year-over-year growth 2023-2028 (%)
        • Data Table on UK - Year-over-year growth 2023-2028 (%)
      • 8.10 Canada - Market size and forecast 2023-2028
        • Chart on Canada - Market size and forecast 2023-2028 ($ million)
        • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
        • Chart on Canada - Year-over-year growth 2023-2028 (%)
        • Data Table on Canada - Year-over-year growth 2023-2028 (%)
      • 8.11 China - Market size and forecast 2023-2028
        • Chart on China - Market size and forecast 2023-2028 ($ million)
        • Data Table on China - Market size and forecast 2023-2028 ($ million)
        • Chart on China - Year-over-year growth 2023-2028 (%)
        • Data Table on China - Year-over-year growth 2023-2028 (%)
      • 8.12 Market opportunity by geography
        • Market opportunity by geography ($ million)
        • Data Tables on Market opportunity by geography ($ million)

      9 Drivers, Challenges, and Opportunity/Restraints

      • 9.1 Market drivers
        • 9.2 Market challenges
          • 9.3 Impact of drivers and challenges
            • Impact of drivers and challenges in 2023 and 2028
          • 9.4 Market opportunities/restraints

            10 Competitive Landscape

            • 10.1 Overview
              • 10.2 Competitive Landscape
                • Overview on criticality of inputs and factors of differentiation
              • 10.3 Landscape disruption
                • Overview on factors of disruption
              • 10.4 Industry risks
                • Impact of key risks on business

              11 Competitive Analysis

              • 11.1 Companies profiled
                • Companies covered
              • 11.2 Market positioning of companies
                • Matrix on companies position and classification
              • 11.3 Bayer AG
                • Bayer AG - Overview
                • Bayer AG - Business segments
                • Bayer AG - Key news
                • Bayer AG - Key offerings
                • Bayer AG - Segment focus
              • 11.4 Boehringer Ingelheim International GmbH
                • Boehringer Ingelheim International GmbH - Overview
                • Boehringer Ingelheim International GmbH - Product / Service
                • Boehringer Ingelheim International GmbH - Key news
                • Boehringer Ingelheim International GmbH - Key offerings
              • 11.5 Ceva Sante Animale
                • Ceva Sante Animale - Overview
                • Ceva Sante Animale - Product / Service
                • Ceva Sante Animale - Key offerings
              • 11.6 Dechra Pharmaceuticals Plc
                • Dechra Pharmaceuticals Plc - Overview
                • Dechra Pharmaceuticals Plc - Business segments
                • Dechra Pharmaceuticals Plc - Key offerings
                • Dechra Pharmaceuticals Plc - Segment focus
              • 11.7 Heska Corp.
                • Heska Corp. - Overview
                • Heska Corp. - Business segments
                • Heska Corp. - Key offerings
                • Heska Corp. - Segment focus
              • 11.8 IDEXX LABORATORIES INC.
                • IDEXX LABORATORIES INC. - Overview
                • IDEXX LABORATORIES INC. - Business segments
                • IDEXX LABORATORIES INC. - Key news
                • IDEXX LABORATORIES INC. - Key offerings
                • IDEXX LABORATORIES INC. - Segment focus
              • 11.9 Indian Immunologicals Ltd.
                • Indian Immunologicals Ltd. - Overview
                • Indian Immunologicals Ltd. - Product / Service
                • Indian Immunologicals Ltd. - Key offerings
              • 11.10 Merck and Co. Inc.
                • Merck and Co. Inc. - Overview
                • Merck and Co. Inc. - Business segments
                • Merck and Co. Inc. - Key news
                • Merck and Co. Inc. - Key offerings
                • Merck and Co. Inc. - Segment focus
              • 11.11 Virbac Group
                • Virbac Group - Overview
                • Virbac Group - Business segments
                • Virbac Group - Key news
                • Virbac Group - Key offerings
                • Virbac Group - Segment focus
              • 11.12 Zoetis Inc.
                • Zoetis Inc. - Overview
                • Zoetis Inc. - Business segments
                • Zoetis Inc. - Key news
                • Zoetis Inc. - Key offerings
                • Zoetis Inc. - Segment focus

              12 Appendix

              • 12.1 Scope of the report
                • 12.2 Inclusions and exclusions checklist
                  • Inclusions checklist
                  • Exclusions checklist
                • 12.3 Currency conversion rates for US$
                  • Currency conversion rates for US$
                • 12.4 Research methodology
                  • Research methodology
                • 12.5 Data procurement
                  • Information sources
                • 12.6 Data validation
                  • Data validation
                • 12.7 Validation techniques employed for market sizing
                  • Validation techniques employed for market sizing
                • 12.8 Data synthesis
                  • Data synthesis
                • 360 degree market analysis
                  • 360 degree market analysis
                • 12.10 List of abbreviations
                  • List of abbreviations

                Research Methodology

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                Interested in this report?

                Get your sample now to see our research methodology and insights!

                Download Now

                Frequently Asked Questions

                Companion Animal Healthcare market growth will increase by $ 10840.4 mn during 2024-2028 .

                The Companion Animal Healthcare market is expected to grow at a CAGR of 10.03% during 2024-2028 .

                Companion Animal Healthcare market is segmented by Product( Pharmaceuticals, Diagnostics)

                Agrolabo Spa, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Eco Animal Health Group Plc, Elanco Animal Health Inc., Endovac Animal Health, Heska Corp., IDEXX LABORATORIES INC., Indian Immunologicals Ltd., Inovet, Kyoritsuseiyaku Corp., HIPRA S A, Merck and Co. Inc., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, Zoetis Inc. are a few of the key vendors in the Companion Animal Healthcare market.

                North America will register the highest growth rate of 45% among the other regions. Therefore, the Companion Animal Healthcare market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

                US, Germany, UK, Canada, China

                • Rising pet ownershipGrowing pet ownership and humanization of pets are complementing the growth of the global companion animal healthcare market during the forecast period. Most pet owners believe that pets have a positive impact on their lives. Around 90% of dog owners is the driving factor this market.
                • specifically is the driving factor this market.
                • believe that their dogs make a huge contribution to their physical and mental health. According to the American Pet Products Association (APPA) 2020-2021 APPA National Pet Owners Survey is the driving factor this market.
                • over 67% of American households is the driving factor this market.
                • which equates to 84.9 million homes is the driving factor this market.
                • own at least one pet in their house. Therefore is the driving factor this market.
                • the increasing adoption of pets in households is driving the demand for animal healthcare units for the purposes of check-ups on pet's health conditions is the driving factor this market.
                • propelling the growth of the global companion animal healthcare market during the forecast period. is the driving factor this market.

                The Companion Animal Healthcare market vendors should focus on grabbing business opportunities from the Pharmaceuticals segment as it accounted for the largest market share in the base year.